PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
Visit https://www.peervoice.com/UHN860 to view the entire programme with slides. After completing “Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them”, participants will be able to: Describe the efficacy and safety data for recent treatment options for metastatic triple-negative breast cancer (mTNBC); Evaluate the clinical implications of the evidence for new treatments on real-life practices; Identify which patients are most likely to benefit from the new treatment options, such as the TROP2-directed antibody drug-conjugate (ADC) therapies.